Pharmacogenomics Archives - Myogenes

Pharmacogenomics

Treatment Resistant Depression: What Is It?

Treatment Resistant Depression: What Is It?

According to the World Health Organisation, depression is the leading cause of disability in the world. According to estimates from the NHS, 264 million people worldwide suffer from depression, and 1 in 4 people in England will experience some form of mental health...

Getting Pharmacogenomics into the Clinic

Getting Pharmacogenomics into the Clinic

Getting Pharmacogenomicsinto the Clinic This Medical News Article Discusses Barriers to Widespread Implementation of Genotype-Guided Prescribing What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to...

Improving the Effectiveness of Bipolar Medication

Improving the Effectiveness of Bipolar Medication

To mark World Bipolar Day on 30 March, in this blog we are looking at the role of medication in managing bipolar disorder and asking what can be done to improve its effectiveness and reduce the risk of unwanted side-effects. What is bipolar disorder? Bipolar disorder...